Related Experiment Video
Updated: Jul 15, 2026

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
RecoverEsupport-A Digital Health Intervention for Recovery After Breast Cancer Surgery: Feasibility and Acceptability
Emma Sansalone1,2, Erin Forbes1, Anna Palazzi-Parsons1,2
1School of Medicine and Public Health, University of Newcastle, 150 University Drive, Callaghan, New South Wales, 2308, Australia, 61 2 4042 0964.
The RecoverEsupport Breast digital health intervention (DHI) for breast cancer surgery recovery was acceptable and safe, with high participant engagement. However, recruitment challenges indicate a need for improved strategies before a full trial.
Area of Science:
- Oncology
- Digital Health
- Surgical Recovery
Background:
- Optimizing recovery after breast cancer surgery is crucial for patient function and adjuvant therapy.
- Enhanced Recovery After Surgery (ERAS) protocols guide patient behaviors like early mobilization and nutrition.
- Adherence to ERAS protocols is often suboptimal, highlighting a need for supportive strategies.
Purpose of the Study:
- To assess the acceptability of the RecoverEsupport Breast digital health intervention (DHI).
- To evaluate the feasibility of a randomized controlled trial for the DHI.
- To improve adherence to ERAS recommendations in breast cancer surgery patients.
Main Methods:
- A single-site, 2-arm randomized pilot trial involving mastectomy patients.
- Participants received usual care or usual care plus the RecoverEsupport DHI.
- Feasibility assessed by recruitment, retention, data completeness, and safety; acceptability by usability, engagement, and recommendation.
Main Results:
- Recruitment (23/70) was below target, but retention and data completeness were 100%.
- No severe adverse events occurred; acceptability targets were met, with high usability (83.2/100) and recommendation rates (88%).
- Three of four feasibility targets were met, indicating a need for revised recruitment strategies.
Conclusions:
- The RecoverEsupport DHI is acceptable, safe, and engaging for breast cancer surgery patients.
- Trial feasibility was demonstrated, but recruitment barriers require addressing.
- Further development of recruitment strategies is necessary for a full-scale randomized controlled trial.
More Related Videos
06:03Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
03:07Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025